Related Experiment Video
Updated: Apr 25, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
A new series of HAPs as anti-HBV agents targeting at capsid assembly
Xiu-yan Yang1, Xiao-qian Xu1, Hua Guan2
1School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, PR China; Department of Medicinal Chemistry, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, PR China.
Abstract:
A series of novel Heteroaryldihydropyrimidines (HAPs) derivatives were designed and synthesized as potent inhibitors of HBV capsid assembly. These compounds were prepared from efforts to optimize an earlier series of HAPs, and compounds Mo1, Mo7, Mo8, Mo10, Mo12, and Mo13 demonstrated potent inhibition of HBV DNA replication at submicromolar range.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Viral Hepatitis I: Introduction
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

